Report shows investments save lives and dollars
The U.S. government invested $12.7 billion over the past decade in the creation of new vaccines, drugs, diagnostics and other products for neglected diseases in the developing world. That’s according to a new report released by the Global Health Technologies Coalition (GHTC) and Policy Cures on Friday.
Of the 45 new products registered in that time to address these neglected diseases that affect more than 1 billion people around the world, the U.S. was involved in the development of 24 of them (or 52 percent).
The late breaker session at the 2nd International Treatment as Prevention Workshop in Vancouver Wednesday offered some interesting insights relevant to HIV treatment scale up. Home-based testing Nathan Ford from Medicines Sans Frontieres (MSF or Doctors Without Borders) offered findings from a meta-analysis of home-based testing studies. Their analysis found that home-based testing was an […]
To commemorate World Malaria Day, top malaria researchers came together Wednesday to present their work at a research and development event on Capitol Hill, hosted by Malaria No More. Representatives from 20 academic and research organizations discussed the contributions American private companies, universities and research institutions are making to the fight against malaria through R&D. […]
Stephen Lawn reminded the audience at the International Treatment as Prevention Workshop in Vancouver on Wednesday that antiretroviral therapy (ART) goes a long way to protect HIV-infected individuals from tuberculosis (TB). The HIV-associated TB epidemic requires “radical interventions,” according to Lawn. “DOTS [directly observed TB therapy, short course] just isn’t doing it.” He called the […]
Chewe Luo, a senior adviser for UNICEF, discussed efforts to eliminate vertical HIV transmission from the perspective of treatment as prevention at the International Treatment as Prevention Workshop on Wednesday in Vancouver. She acknowledged that the maternal and child health platform could be a very effective entry point for treatment as prevention and for the […]
On a new webpage developed by the U.S. Agency for International Development (USAID), there are some cute pictures of five-year-old faces that might look familiar. Visitors can see a five-year-old version of actress Mandy Moore sporting a tutu, a teeny Sen. John Kerry (D-MA) on a toboggan in the snow, and even a wee USAID Administrator […]
Vladimir Novitsky, from the Harvard School of Public Health, offered the audience at the International Treatment as Prevention Workshop in Vancouver a snapshot of a four-year treatment as prevention study planned for Botswana. Botswana has the highest antiretroviral therapy (ART) coverage rate in southern Africa with more than 90 percent of individuals with CD4 counts […]
Dr. Zunyou Wu, Director of the Chinese Center for Disease Control and Prevention (CDC), offered the audience at the 2nd International Treatment as Prevention Workshop in Vancouver new information about China’s response to new evidence on treatment as prevention. The first response in 2011 was to scale up testing and treatment. In 2011, more than […]
Capitol Hill briefing sheds light on imminent emergence of drug-resistant gonorrhea
Testament to “too many years of neglect of investments in sexually transmitted diseases (STDs),” a gonorrhea superbug is expected to make its appearance in the U.S. within the near future. That’s according to a panel of experts that spoke at a Capitol Hill briefing Friday hosted by Rep. Barbara Lee’s (D-CA) office along with the National Coalition of STD Directors…
Despite its status as one of the poorest countries in Africa and its failed effort to garner a Round 10 grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria – Malawi is moving forward to implement “Option B+” for pregnant women. This means that pregnant and lactating women are enrolled in antiretroviral therapy […]